These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31402494)

  • 1. Challenges in the quality of herbal medicinal products with a specific focus on contaminants.
    Steinhoff B
    Phytochem Anal; 2021 Apr; 32(2):117-123. PubMed ID: 31402494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review: Quality of herbal medicinal products: State of the art of purity assessment.
    Steinhoff B
    Phytomedicine; 2019 Jul; 60():153003. PubMed ID: 31327654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrrolizidine Alkaloid Contamination in Medicinal Plants: Regulatory Requirements and Their Impact on Production and Quality Control of Herbal Medicinal Products.
    Steinhoff B
    Planta Med; 2022 Feb; 88(2):125-129. PubMed ID: 34041723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrrolizidine alkaloid contamination in herbal medicinal products: Limits and occurrence.
    Steinhoff B
    Food Chem Toxicol; 2019 Aug; 130():262-266. PubMed ID: 31121208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory Perspectives of Pyrrolizidine Alkaloid Contamination in Herbal Medicinal Products.
    Wiesner J
    Planta Med; 2022 Feb; 88(2):118-124. PubMed ID: 34169489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union.
    Kroes BH
    J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contaminants of medicinal herbs and herbal products.
    Kosalec I; Cvek J; Tomić S
    Arh Hig Rada Toksikol; 2009 Dec; 60(4):485-501. PubMed ID: 20061249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic pyrrolizidine alkaloids in herbal medicines commonly used in Ghana.
    Letsyo E; Jerz G; Winterhalter P; Beuerle T
    J Ethnopharmacol; 2017 Apr; 202():154-161. PubMed ID: 28284793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Findings on the heavy metal content in herbal drugs and essential oils - an update.
    Albert H; Klier B; Knödler M; Steinhoff B
    Pharmeur Bio Sci Notes; 2018; 2018():62-111. PubMed ID: 30272556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-European traditional herbal medicines in Europe: a community herbal monograph perspective.
    Qu L; Zou W; Zhou Z; Zhang T; Greef J; Wang M
    J Ethnopharmacol; 2014 Oct; 156():107-14. PubMed ID: 25169214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Legal requirements for the quality of herbal substances and herbal preparations for the manufacturing of herbal medicinal products in the European union.
    Vlietinck A; Pieters L; Apers S
    Planta Med; 2009 Jun; 75(7):683-8. PubMed ID: 19204891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Extractable Elements from Elastomers.
    Paskiet D; Kraft C; Tullo E; Hunter J; Zurbriggen D
    PDA J Pharm Sci Technol; 2019; 73(1):83-91. PubMed ID: 30030347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current findings on the heavy metal content in herbal drugs.
    Gasser U; Klier B; Kühn AV; Steinhoff B
    Pharmeur Sci Notes; 2009 Mar; 2009(1):37-50. PubMed ID: 19275871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Level of Cadmium Impurities in Traditional Herbal Medicinal Products with Plantago lanceolata L., folium (Ribwort Plantain Leaves) Available in Polish Pharmacies - Comprehensive Toxicological Risk Assessment Including Regulatory Point of View and ICH Q3D Elemental Impurities Guideline.
    Jurowski K; Fołta M; Tatar B; Krośniak M
    Biol Trace Elem Res; 2022 Jun; 200(6):2963-2969. PubMed ID: 34373979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of genotoxicity of herbal medicinal products: application of the "bracketing and matrixing" concept using the example of Valerianae radix (valerian root).
    Kelber O; Wegener T; Steinhoff B; Staiger C; Wiesner J; Knöss W; Kraft K
    Phytomedicine; 2014; 21(8-9):1124-9. PubMed ID: 24837473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Removal of Pyrrolizidine Alkaloids from Essential Oils by the Hydrodistillation Step in Their Manufacturing Process.
    Giera DS; Preisitsch M; Brevard H; Nemetz J
    Planta Med; 2022 Jun; 88(7):538-547. PubMed ID: 34293805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory issues concerning the safety, efficacy and quality of herbal remedies.
    Rousseaux CG; Schachter H
    Birth Defects Res B Dev Reprod Toxicol; 2003 Dec; 68(6):505-10. PubMed ID: 14745988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Human Health Risk Assessment of Heavy Metals Impurities (Cd and Pb) in Herbal Medicinal Products as
    Jurowski K; Krośniak M
    Toxics; 2022 May; 10(5):. PubMed ID: 35622685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of medicinal plants for public health--European community monographs on herbal substances.
    Knöss W; Chinou I
    Planta Med; 2012 Aug; 78(12):1311-6. PubMed ID: 22618374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some aspects of toxic contaminants in herbal medicines.
    Chan K
    Chemosphere; 2003 Sep; 52(9):1361-71. PubMed ID: 12867165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.